Delivery Order SPE2DB24D1205-SPE2DB24FCRJK
Award Date 5/16/24
Potential Completion Date 5/17/24
Potential Value $4.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $2,813.80 for the provision of 40 mg VYVANSE capsules. The contract is issued by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $6,133.16 for the supply of VYVANSE 30 MG CAPSULE 100S. The contract is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, and has a period of performance through November 25, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The contract is for the provision of 4565091441 VYVANSE 30 MG CAPSULE 100S, a pharmaceutical product, with a ceiling value of $2,819.90. The contract does not have a set-aside designation and was awarded on a full...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,567.13 to provide VYVANSE 30 MG CAPSULE 100S to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of November 27, 2024 and is a Firm Fixed Price arrangement. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a primary...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a $6,400.84 Firm Fixed Price delivery order for the pharmaceutical product VYVANSE CAPS 30MG. The contract was awarded on June 28, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, a unit of the U.S. Department of Defense (DoD), with an ultimate completion date of July 1, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,343.49 firm fixed-price delivery order is for the supply of 4,563,886,982 units of VYVANSE 10 MG CAPSULE 100S. The contract has an ultimate completion date of March 8, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), an agency within the U.S. Department of Defense. The contract is a delivery order with a firm fixed price of $1,337.70 and a completion date of May 29, 2025. The contract provides for the delivery of 4,568,376,034 units of the prescription medication VYVANSE 30 MG CAPSULE 100S. This contract is not set aside for any specific...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,958.65 Firm Fixed Price Delivery Order contract is for the provision of VYVANSE 40 MG CAPSULE 100S, a medication, with an ultimate completion date of February 12, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,375,484 units of VYVANSE 70 MG CAPSULE 100S, a pharmaceutical product, to the U.S. Department of Defense's Medical Supply Chain. The contract, valued at $4,186.98, is a Firm Fixed Price Delivery Order with an ultimate completion date of April 23, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,008.04 firm fixed price delivery order is for the supply of VYVANSE 30 MG CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of March 25, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...